Rottenstein Law Group Marks Inefficacy of Vibration Treatment for Osteoporosis

November 21, 2011

The Rottenstein Law Group, which represents clients with claims of harm resulting from use of the drug Fosamax, notes with some regret a report that a âœnovel treatment known as whole-body vibration doesnât appear to improve the bone health of postmenopausal women who are at high risk of developing osteoporosis.â

New York, NY (PRWEB) November 21, 2011

According to a November 15 piece published by U.S. News and World Report, the treatment, âœwhich involves standing on a motorized, vibrating platform in the hope of building bone mass⦠showed promise in animals. But researchers, who hoped those results might translate to humans, found no benefit for women who used the platforms for a year,â according to study co-author Angela M. Cheung, an internist and director of the osteoporosis program at the University Health Network, University of Toronto, quoted in the piece.

The report notes that Dr. Joseph Lane, professor of orthopedic surgery at Weill Medical College of Cornell University, said âœthe study appears valid and debunks the use of whole-body therapy to treat bone loss. Currently, he said, bisphosphonate medications such as Fosamax are the best initial treatment for bone lossâ¦.â

But Fosamax is not without its own problems. Despite being the most popular osteoporosis treatment medication on the market, Fosamax has been linked to several serious side effects. In 2004, researchers found a causal connection between Fosamax and osteonecrosis of the jaw, a condition where the jawbone dies due to a lack of blood supply. More recently, people have suffered low-impact femur fractures after falling from standing height or less. Evidence is building that taking Fosamax or similar medications for the treatment of osteoporosis causes a dramatic increase in risk of this particular kind of rare fracture to the thigh bone, all as reported by the New York Times.

As of June 30, 2011, according to Merck itself, approximately 1,650 cases, which include approximately 2,050 plaintiff groups, had been filed and were pending against Merck in either federal or state court. The Rottenstein Law Group urges anyone whose friend or relative has been prescribed Fosamax or another osteoporosis drug to reach out to that person and recommend that he or she consult a physician immediately and then speak to a qualified personal injury lawyer. The Rottenstein Law Group maintains a Fosamax Femur Fracture Lawsuit Information Center at http://www.fosamaxfemurfracturelawsuit.com. The site has features that allow for easy sharing, including links for automatic posting on Facebook and Twitter, specifically to enable visitors to spread the word about the dangers of Fosamax.


The Rottenstein Law Group is a New York-based law firm that represents clients in dangerous drug lawsuits. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective consumer products. http://www.rotlaw.com


The Rottenstein Law Group, LLP

Rochelle Rottenstein, Esq.

1259 Veeder Drive

Hewlett NY 11557

(212) 933-9500 (office phone)

(212) 933-9980 (facsimile)




For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/11/prweb8969160.htm

Source: prweb

comments powered by Disqus